The reproductive system poses distinct physiological challenges for effective drug delivery, necessitating innovative strategies to navigate various biological barriers, including the blood-testis barrier, vaginal mucosa, and cervix. Targeted drug delivery is essential for addressing prevalent conditions that require therapeutic intervention, such as reproductive cancers, infertility, and sexually transmitted infections. Recent advancements in drug delivery systems, particularly those utilizing nanotechnology, have demonstrated significant potential in enhancing the therapeutic efficacy of various agents. Platforms like nanoparticles and liposomes facilitate targeted drug delivery, whereas hydrogels and biodegradable polymers enable localized and controlled release of therapeutics. Innovations in injectable and implantable systems, such as drug-eluting intrauterine devices and subdermal implants, have further optimized sustained drug release mechanisms. Additionally, micro- and nano-needles offer minimally invasive methods for direct administration to reproductive tissues. Route-specific delivery methods, including vaginal, uterine, and penile applications, have been investigated to improve bioavailability and patient compliance. Moreover, targeted and precision medicine approaches, encompassing gene therapy and personalized medicine, are advancing tailored treatment protocols based on individual genetic and molecular profiles. The therapeutic landscape includes applications in assisted reproductive technologies and the management of reproductive cancers and infections, highlighting the transformative potential of advanced drug delivery systems to enhance patient outcomes. Nonetheless, considerations regarding safety and regulatory compliance remain paramount in the development and application of these innovative therapies, emphasizing the need for ongoing research in this critical domain of reproductive health.